We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$190M
AUM Growth
+$20.7M
Cap. Flow
+$20.1M
Cap. Flow %
10.54%
Top 10 Hldgs %
5.58%
Holding
804
New
341
Increased
82
Reduced
54
Closed
326

Top Buys

1
UGI icon
UGI
UGI
+$1.2M
2
GILD icon
Gilead Sciences
GILD
+$1.06M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.05M
4
WM icon
Waste Management
WM
+$1.04M
5
H icon
Hyatt Hotels
H
+$1.03M

Top Sells

1
IP icon
International Paper
IP
+$1.5M
2
FTNT icon
Fortinet
FTNT
+$1.03M
3
CHKP icon
Check Point Software Technologies
CHKP
+$978K
4
ALB icon
Albemarle
ALB
+$881K
5
MOH icon
Molina Healthcare
MOH
+$869K

Sector Composition

1 Technology 15.74%
2 Healthcare 13.65%
3 Consumer Discretionary 12.28%
4 Industrials 11.23%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UGI icon
1
UGI
UGI
$7.9B
$1.23M 0.65%
+26,700
New +$1.2M
MGM icon
2
MGM Resorts International
MGM
$12B
$1.15M 0.6%
39,900
+29,000
+266% +$803K
IWM icon
3
iShares Russell 2000 ETF
IWM
$82.2B
$1.1M 0.58%
+8,188
New +$1.05M
WM icon
4
Waste Management
WM
$97.3B
$1.1M 0.58%
+15,500
New +$1.04M
H icon
5
Hyatt Hotels
H
$17.8B
$1.07M 0.56%
+19,400
New +$1.03M
AMT icon
6
American Tower
AMT
$78.7B
$1.02M 0.54%
9,700
+6,100
+169% +$663K
GILD icon
7
Gilead Sciences
GILD
$169B
$1.02M 0.54%
+14,300
New +$1.06M
CNQ icon
8
Canadian Natural Resources
CNQ
$89.4B
$995K 0.52%
63,710
+39,002
+158% +$618K
INXN
9
DELISTED
Interxion Holding N.V.
INXN
$961K 0.51%
+27,400
New +$975K
NBIX icon
10
Neurocrine Biosciences
NBIX
$17.2B
$960K 0.5%
24,800
+20,500
+477% +$928K
HOG icon
11
Harley-Davidson
HOG
$2.82B
$898K 0.47%
15,400
+9,000
+141% +$513K
CXW icon
12
CoreCivic
CXW
$3.03B
$885K 0.47%
36,200
-33,100
-48% -$631K
AVNS icon
13
Avanos Medical
AVNS
$1.17B
$880K 0.46%
+23,800
New +$851K
BSX icon
14
Boston Scientific
BSX
$66.3B
$870K 0.46%
+40,200
New +$877K
GIL icon
15
Gildan
GIL
$9.92B
$870K 0.46%
+34,300
New +$913K
AXP icon
16
American Express
AXP
$247B
$852K 0.45%
11,500
+7,000
+156% +$485K
AR icon
17
Antero Resources
AR
$10.3B
$828K 0.44%
+35,000
New +$898K
WIX icon
18
WIX.com
WIX
$2.21B
$824K 0.43%
+18,500
New +$835K
HPE icon
19
Hewlett Packard
HPE
$59.8B
$815K 0.43%
+60,564
New +$809K
IQV icon
20
IQVIA
IQV
$35.1B
$806K 0.42%
10,600
+7,300
+221% +$560K
AGCO icon
21
AGCO
AGCO
$8.35B
$804K 0.42%
13,900
+8,700
+167% +$470K
VLO icon
22
Valero Energy
VLO
$89.2B
$799K 0.42%
+11,700
New +$720K
FMC icon
23
FMC
FMC
$1.43B
$797K 0.42%
16,257
+2,882
+22% +$132K
POST icon
24
Post Holdings
POST
$3.98B
$788K 0.41%
14,974
+4,889
+48% +$247K
CVLT icon
25
Commault Systems
CVLT
$6.2B
$786K 0.41%
15,300
+11,300
+283% +$606K
1
2 3 4 5

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q4 2016 Portfolio in Review

As of Q4 2016, Fox Run Management held 804 positions worth $190M, up 12% from $170M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Fox Run Management deployed $20.1M of net new capital in Q4 2016, opening 341 new positions and adding to 82 existing holdings. Its largest new stake was UGI: 26,700 shares worth $1.23M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was QIAGEN NV, an estimated $819K trimmed.

  • Fox Run Management's largest Q4 2016 buy was UGI: 26,700 shares worth $1.23M.
  • Fox Run Management added most to Neurocrine Biosciences in Q4 2016, an estimated $928K increase.
  • Fox Run Management's biggest Q4 2016 reduction was QIAGEN NV, cutting an estimated $819K.
  • Fox Run Management fully exited International Paper in Q4 2016, selling an estimated $1.5M.
  • Fox Run Management's ten largest holdings make up 5.6% of its $190M portfolio in Q4 2016.
  • Fox Run Management opened 341 new positions and closed 326 in Q4 2016.
  • Fox Run Management's portfolio value rose 12% quarter-over-quarter to $190M.

Based on Fox Run Management's 13F filing for Q4 2016, filed 10 Jan 2017.